MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief...
Federal recognition establishes ACT as a national leader in online, competency‑based healthcare education—blending virtual training with hands-on clinical placements and registered apprenticeships. Advanced eClinical Training...
Artisight was recognized in the 2025 KLAS Emerging Solutions Top 20 Report for improving healthcare outcomes and patient experience. The Artisight Smart Hospital Platform was...
Andel enables employers to offer GLP-1 weight-loss medications as a benefit — at a fraction of the cost of insurance. At HLTH, Andel announced a $4.5 million capital raise...
AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of upadacitinib (RINVOQ®) 15 mg, once...
Results from a US multicenter study presented at CHEST show e-Lung could have sped up Progressive Pulmonary Fibrosis (PPF) diagnosis by up to 21 months...
HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, and Claritas Rx, the patient journey experts, announced today a strategic partnership to deliver...
Oshi Access+ delivers turn-key clinical staffing to local GI practices and expands access to virtual multidisciplinary care, allowing physicians to practice at the top of...
New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DaVita today announced the launch of two groundbreaking initiatives aimed to deepen the medical...
With backing from Peter Thiel, K5 Global, Jeff Bezos, and Wellington Management, among others, HistoSonics is positioned to expand globally across new clinical applications HistoSonics,...
Integrated Dermatology, the country’s largest independent dermatology provider, announced that George Glinos, MD, has joined the clinical team at Dermatology of Miami. A board-certified dermatologist with...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 96-week findings from PASO DOBLE (GeSIDA...
HARMONi-GI3 is the Fourth Global Phase III Study of Ivonescimab and First Global Study beyond NSCLC Clinical Trial Site Activations Planned to Begin This Quarter...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has acquired Aculys Pharma, Inc., a clinical stage biopharmaceutical company focused on commercializing innovative treatments...